AMGEN INC
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Mailing Address ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Phone (805)447-1000
Fiscal Year End 1231
EIN 953540776
Financial Overview
FY2025
$91.84B
Total Assets
$14.33
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 8-K Current report of material events | February 3, 2026 | View on SEC |
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| 4 Insider stock transaction report | November 21, 2025 | View on SEC |
| 4 Insider stock transaction report | November 13, 2025 | View on SEC |
| 4 Insider stock transaction report | November 13, 2025 | View on SEC |
| 4 Insider stock transaction report | November 12, 2025 | View on SEC |
| 4 Insider stock transaction report | November 12, 2025 | View on SEC |
| 4 Insider stock transaction report | November 12, 2025 | View on SEC |
Annual Reports
10-K February 13, 2026
- Amgen delivered a robust performance in 2025 with significant financial gains, including 10.4% revenue growth and 15.8% net income growth.
- The successful integration of Horizon Therapeutics contributed $4.0 billion to total revenue, alongside strong organic growth from established products.
Related Companies
Companies in the same industry (SIC: 2836)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
PALISADE BIO, INC.
PALI Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.